These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15270901)

  • 1. Imatinib mesylate inhibits the growth of metastatic lung lesions in a patient with dermatofibrosarcoma protuberans.
    Mizutani K; Tamada Y; Hara K; Tsuzuki T; Saeki H; Tamaki K; Matsumoto Y
    Br J Dermatol; 2004 Jul; 151(1):235-7. PubMed ID: 15270901
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp.
    Kasper B; Lossignol D; Gil T; Flamen P; De Saint Aubain N; Awada A
    Anticancer Drugs; 2006 Nov; 17(10):1223-5. PubMed ID: 17075323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imatinib mesylate in the treatment of a large unresectable dermatofibrosarcoma protuberans: a case study.
    Savoia P; Ortoncelli M; Quaglino P; Bernengo MG
    Dermatol Surg; 2006 Aug; 32(8):1097-102. PubMed ID: 16918576
    [No Abstract]   [Full Text] [Related]  

  • 4. Imatinib mesylate treatment for a Chinese patient with metastatic and recurrent dermatofibrosarcoma protuberans: is sustained partial remission possible?
    Wang C; Luo Z; Zheng B; Chen Y; Cao X; Wang J; Zhang R; Shi Y
    Eur J Cancer Prev; 2012 Nov; 21(6):585-7. PubMed ID: 23014697
    [No Abstract]   [Full Text] [Related]  

  • 5. Dermatofibrosarcoma protuberans: a partial response to imatinib therapy.
    Mehrany K; Swanson NA; Heinrich MC; Weenig RH; Lee KK; White CR; Devere TS
    Dermatol Surg; 2006 Mar; 32(3):456-9. PubMed ID: 16640697
    [No Abstract]   [Full Text] [Related]  

  • 6. Halo nevi related to treatment with imatinib in a dermatofibrosarcoma protuberans patient.
    Fava P; Stroppiana E; Savoia P; Bernengo MG
    J Eur Acad Dermatol Venereol; 2010 Feb; 24(2):244-5. PubMed ID: 19694892
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225.
    McArthur GA; Demetri GD; van Oosterom A; Heinrich MC; Debiec-Rychter M; Corless CL; Nikolova Z; Dimitrijevic S; Fletcher JA
    J Clin Oncol; 2005 Feb; 23(4):866-73. PubMed ID: 15681532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.
    Rubin BP; Schuetze SM; Eary JF; Norwood TH; Mirza S; Conrad EU; Bruckner JD
    J Clin Oncol; 2002 Sep; 20(17):3586-91. PubMed ID: 12202658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant imatinib therapy for dermatofibrosarcoma protuberans.
    Han A; Chen EH; Niedt G; Sherman W; Ratner D
    Arch Dermatol; 2009 Jul; 145(7):792-6. PubMed ID: 19620561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyalinized collagen in a dermatofibrosarcoma protuberans after treatment with imatinib mesylate.
    Thomison J; McCarter M; McClain D; Golitz LE; Goldenberg G
    J Cutan Pathol; 2008 Nov; 35(11):1003-6. PubMed ID: 18544062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Good response to treatment with the selective tyrosine-kinase inhibitor imatinib in a patient with metastatic dermatofibrosarcoma protuberans].
    Baars A; Pinedo HM
    Ned Tijdschr Geneeskd; 2003 Oct; 147(42):2072-6. PubMed ID: 14606355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Targeted therapy of dermatofibrosarcoma with imatinib].
    Ugurel S
    J Dtsch Dermatol Ges; 2007 Mar; 5(3):261. PubMed ID: 17338806
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of advanced dermatofibrosarcoma protuberans with imatinib mesylate with or without surgical resection.
    Rutkowski P; Dębiec-Rychter M; Nowecki Z; Michej W; Symonides M; Ptaszynski K; Ruka W
    J Eur Acad Dermatol Venereol; 2011 Mar; 25(3):264-70. PubMed ID: 20569296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Advanced dermatofibrosarcoma protuberans treated with imatinib mesylate].
    Zhu JH; Li QW; Xiao WH; Sun JZ; Wang RL; Lu JY
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):470-2. PubMed ID: 21875491
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imatinib mesylate as a preoperative therapy in dermatofibrosarcoma: results of a multicenter phase II study on 25 patients.
    Kérob D; Porcher R; Vérola O; Dalle S; Maubec E; Aubin F; D'Incan M; Bodokh I; Boulinguez S; Madelaine-Chambrin I; Mathieu-Boue A; Servant JM; de Kerviler E; Janin A; Calvo F; Pedeutour F; Lebbe C
    Clin Cancer Res; 2010 Jun; 16(12):3288-95. PubMed ID: 20439456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effectiveness of imatinib mesylate in treatment for dermatofibroma protuberans].
    Moiseenko VM; Chudenko VA; Orlova RV; Imianitov EN; Matsko DE; Gafton GI; Kochnev VA; Protsenko SA; Mikhaĭlichenko TD; Nogaeva TKh
    Vopr Onkol; 2008; 54(5):656-60. PubMed ID: 19069485
    [No Abstract]   [Full Text] [Related]  

  • 17. Letter: clear margins after the use of imatinib mesylate prior to resection of extensive dermatofibrosarcoma protuberans.
    Ortiz AE; Wu JJ; Linden KG
    Dermatol Surg; 2008 Aug; 34(8):1151. PubMed ID: 18513297
    [No Abstract]   [Full Text] [Related]  

  • 18. Imatinib GIST keeps finding new indications: successful treatment of dermatofibrosarcoma protuberans by targeted inhibition of the platelet-derived growth factor receptor.
    Sawyers CL
    J Clin Oncol; 2002 Sep; 20(17):3568-9. PubMed ID: 12202652
    [No Abstract]   [Full Text] [Related]  

  • 19. Imatinib mesylate for children with dermatofibrosarcoma protuberans (DFSP).
    Gooskens SL; Oranje AP; van Adrichem LN; de Waard-van der Spek FB; den Hollander JC; van de Ven CP; van den Heuvel-Eibrink MM
    Pediatr Blood Cancer; 2010 Aug; 55(2):369-73. PubMed ID: 20582941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive review of imatinib mesylate (Gleevec) for dermatological diseases.
    Scheinfeld N
    J Drugs Dermatol; 2006 Feb; 5(2):117-22. PubMed ID: 16485879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.